Compulsory Licensing High On China Health Regulator’s Policy Agenda
This article was originally published in PharmAsia News
Executive Summary
Compulsory licensing, along with essential drugs and orphan diseases, tops the list of policy issues picked by the National Health Commission’s Drug Policy Bureau, underscoring the willingness and stepped up effort by the Chinese regulator to examine and tackle particularly thorny issues.